REQUEST A DEMO
Total
USD $0.00
Search more companies

K2Pharm S.R.O. (Czech Republic)

Main Activities: All Other Miscellaneous Food Manufacturing
Full name: K2Pharm S.R.O. Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

K2Pharm S.R.O. is based in Czech Republic, with the head office in Opava. The enterprise currently operates in the All Other Miscellaneous Food Manufacturing sector. It was incorporated on June 07, 2013. It currently has a total number of 50 - 99 (2024) employees. From the latest financial highlights, K2Pharm S.R.O. reported a net sales revenue increase of 28.18% in 2023. Its’ total assets recorded a negative growth of 4.4%. The net profit margin of K2Pharm S.R.O. decreased by 2.39% in 2023.

Headquarters
Ratiborska 1651/177
Opava; Moravskoslezsky; Postal Code: 74705

Contact Details: Purchase the K2Pharm S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the K2Pharm S.R.O. report to view the information.
Outstanding Shares:
Purchase the K2Pharm S.R.O. report to view the information.
Registered Capital:
Purchase the K2Pharm S.R.O. report to view the information.
Incorporation Date:
June 07, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after K2Pharm S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
28.18%
Total operating revenue
26.93%
Operating profit (EBIT)
3.36%
EBITDA
-21.65%
Net Profit (Loss) for the Period
-46.65%
Total assets
-4.4%
Total equity
3.57%
Operating Profit Margin (ROS)
-1.62%
Net Profit Margin
-2.39%
Return on Equity (ROE)
-3.24%
Debt to Equity Ratio
-21.15%
Quick Ratio
0.35%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?